ELAN Q1 2019 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$731M-0.7% YoY

Gross Profit

$338M46.3% margin

Operating Income

$93M12.7% margin

Net Income

$32M4.3% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

-8.5%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

-$22M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$8.7B

Total Liabilities

$3.6B

Stockholders' Equity

$5.2B

Cash & Equivalents

$272M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$731M	$736M	-0.7%
Gross Profit	$338M	$327M	+3.5%
Operating Income	$93M	$82M	+13.8%
Net Income	$32M	$73M	-56.7%

Revenue Segments

Food Animal Ruminants And Swine

$274M37%

Companion Animal Disease Prevention

$186M25%

Food Animal Future Protein And Health

$167M23%

Companion Animal Therapeutics

$81M11%

Companion Animal Other

$23M3%

Geographic Segments

UNITED STATES

$384M53%

Non-US

$347M47%